ADAM17: A Therapeutic Target for Patients with Emphysema?

被引：1
|
作者：
Jundi, Bakr [1 ]
Geraghty, Patrick [1 ]
机构：
[1] SUNY Downstate Hlth Sci Univ, Dept Med, Brooklyn, NY 11203 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY | 2021年 / 64卷 / 02期
关键词：
ALPHA-CONVERTING-ENZYME; EXPRESSION;
D O I：
10.1165/rcmb.2020-0467ED
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：155 / 157
页数：3
相关论文
共 50 条
  • [1] ADAM17 as a Therapeutic Target in Multiple Diseases
    Arribas, Joaquin
    Esselens, Cary
    CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (20) : 2319 - 2335
  • [2] ADAM17: An Emerging Therapeutic Target for Lung Cancer
    Saad, Mohamed, I
    Rose-John, Stefan
    Jenkins, Brendan J.
    CANCERS, 2019, 11 (09)
  • [3] ADAM17: A new therapeutic target for triple negative breast cancer?
    McGowan, P.
    Mullooly, M.
    Sukor, S.
    O'Donovan, N.
    Duffy, M. J.
    EJC SUPPLEMENTS, 2010, 8 (07): : 47 - 47
  • [4] ADAM17 Deficiency Protects against Pulmonary Emphysema
    Saad, Mohamed, I
    McLeod, Louise
    Hodges, Christopher
    Vlahos, Ross
    Rose-John, Stefan
    Ruwanpura, Saleela
    Jenkins, Brendan J.
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2021, 64 (02) : 183 - 195
  • [5] ADAM17: A novel treatment target for aneurysms
    Bai, Hualong
    Zhang, Liwei
    Sun, Peng
    Wu, Haoliang
    Li, Mingxing
    Gu, Yulei
    Zhang, Cong
    Lou, Chunyang
    Li, Jing'an
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 148
  • [6] ADAM17, shedding, TACE as therapeutic targets
    Rose-John, Stefan
    PHARMACOLOGICAL RESEARCH, 2013, 71 : 19 - 22
  • [7] ADAM17 as a novel therapeutic target for HER2-positive breast cancer
    Sukor, Sumainizah
    McGowan, Patricia M.
    Mullooly, Maeve
    Pierce, Aisling
    Crown, John
    O'Donovan, Norma
    Duffy, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [8] ADAM17: A Novel Therapeutic Target for Treatment of Triple Negative Breast Cancer.
    McGowan, P. M.
    Mullooly, M.
    Sukor, S.
    Madden, S.
    McDermott, E.
    Pierce, A.
    Crown, J.
    O'Donovan, N.
    Duffy, M. J.
    CANCER RESEARCH, 2011, 71
  • [9] ADAM17 as a Therapeutic Target for the Treatment of Breast Cancer: Preclinical Studies with an Inhibitory Monoclonal Antibody
    Caiazza, F.
    Murphy, G.
    McGowan, P. M.
    Crown, J.
    Duffy, M. J.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 162 - 163
  • [10] ADAM17/TACE is a novel target of the unfolded protein response
    Petry, A.
    Rzymski, T.
    Kracun, D.
    Riess, F.
    Pike, L.
    Harris, A. L.
    Gorlach, A.
    CARDIOVASCULAR RESEARCH, 2012, 93 : S95 - S95
12345